You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Prapela® SVS incubator pad: A cost-effective stochastic vibrotactile device to improve the clinical course of infants with apnea of prematurity.
SBC: PRAPELA INC Topic: NIDAPrapela proposes to complete the development of and then establish the safety, efficacy, and clinical risk/benefit of a novel hospital incubator pad that will provide a complementary treatment and the first improvement in the clinical management of apnea of prematurity (AOP) in over 20 years. Defined as cessation of breathing for 20 seconds or longer or a shorter pause accompanied by hypoxemia, AO ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
SBC: ABBRATECH INC. Topic: 300ABSTRACT Current therapeutic antibodies target the cell surface and within the external cellular environment. Yet intracellular proteins make up half of the proteome. Having a facile means of targeting those intracellular proteins for the generation of therapeutic antibodies would be highly desirable. Targeting MHC complexed with neoantigens from intracellular proteins would greatly allow the gene ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Development of an empathetic chatbot to monitor perinatal mental health longitudinally
SBC: Poisera, Inc. Topic: 1041 ABSTRACT2 One in five pre- or postnatal women will develop a perinatal mood disorder (PMD). While temporary and3 treatable, 50-65% of mothers with PMD symptoms never receive a diagnosis or treatment due to inadequate4 screening practices. PMDs remain undetected because mothers do not trust clinicians due to fear of judgment,5 stigma, or even loss of parental rights. Untreated PMDs increase risk ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Augmented Reality Personalized Motion Tracking Assessment and Improvement Technology for Fall Prevention for the Spanish Speaking Hispanic/Latino Population in a Community Setting Using Mobile Phone
SBC: KINIMA, INC. Topic: NIAMore than 1 in 4 people 65 and older fall each year, leading to more than $50 billion in annual spending for treatment. This cost is on an upward trajectory. We have less understanding of the impact of falls and risk in the Spanish-speaking Hispanic/Latino population. Although a variety of community-based public health programs are addressing fall prevention, these programs are in English and are ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Topical Eyedrops Increasing Lysyl Oxidase Activity to Control Myopia
SBC: Iveena Delivery Systems, Inc. Topic: NEIProject Summary Pediatric myopia, also known as nearsightedness, is an eye condition in which one is unable to bring distant objects into proper focus. It is the leading cause of vision impairment in the world. The estimated economic impact of uncorrected refractive error is estimated to be a loss of $202 billion of global gross domestic product. The prevalence of myopia and high myopia are increa ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
PANK Activators for the treatment of pantothenate kinase-associated neurodegeneration
SBC: Virtus Therapeutics Corporation Topic: NINDSSUMMARY Pantothenate kinase-associated neurodegeneration, PKAN, is a rare progressive neurodegenerative disorder associated with iron accumulation in the brain. The disease causes early immobility and often death by early adulthood. PKAN is caused by mutations in one of four human pantothenate kinase genes, PANK2 gene, which encodes a mitochondrial pantothenate kinase. Consistent with the clinical ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Development of a Novel Resolvin-Based Therapy for Treatment of Pancreatic Cancer
SBC: Thetis Pharmaceuticals LLC Topic: 102ABSTRACT Pancreatic cancer (PC) is a highly lethal disease with a 5-year survival rate between 5% and 10%. PC incidence and mortality are projected to more than double over the next ten years. However, existing systemic chemotherapies have limited efficacy along with significant side effects and safety issues, and targeted and immunotherapies have not been effective. Emerging data demonstrates tha ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Multisensory Augmented Reality as a bridge to audio-only accommodations for inclusive STEM interactive digital media
SBC: ALCHEMIE SOLUTIONS, INC. Topic: 500Only 3% of individuals who are blind or have low vision (BLV) have been employed in a STEM field. The lack of accessible accommodations to visually rich dynamic STEM content creates roadblocks to success for BLV students in STEM education throughout their academic journey. The goal of this SBIR is a usable system of accommodations for Interactive Digital Media (IDM), so students with profound visu ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Antifungals targeting pantothenate phosphorylation
SBC: CURATIX, LLC Topic: NIAIDSUMMARY Invasive fungal infections (IFIs) create significant healthcare and economic burdens as they are responsible for more than one billion infections worldwide each year resulting in more than 1.5 million deaths. Hospital patients who acquire nosocomial IFIs experience longer hospital stays, increased morbidity, and higher mortality rates. Only a few classes of antifungal drugs are available, ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health -
Addressing the wireless power problem: A low-power hybrid radio for neuroscience experiments
SBC: SPIKE NEURO LLC Topic: 101Project Summary Closed-loop stimulation is key to the study and treatment of neurological disorders. However, largely due to current wireless power demands, stimulation systems are restricted to wired connections, which impact natural behavior, induce motion artifacts, and limit complexity of study design. While a few wireless recording- only systems have been developed, the power demands of these ...
SBIR Phase I 2023 Department of Health and Human ServicesNational Institutes of Health